Assembly Biosciences, Inc. (ASMB) Misses Q1 EPS by $1.39

Assembly Biosciences, Inc. (NASDAQ: ASMB) reported Q1 EPS of ($1.66), $1.39 worse than the analyst estimate of ($0.27). Revenue for the quarter came in at $5.79 million.

For earnings history and earnings-related data on Assembly Biosciences, Inc. (ASMB) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• Assembly Biosciences to Present at the H.C. Wainwright & Co. 28th Annual Global Investment Conference
• S&P 500 above 8,000 in 2026 now looks ambitious, Citi says